Home The crystal structure of 1-((5-chloro-3-methyl-1-phenyl-1H-pyrazole-4-yl)methyl)-1,3-diphenylurea, C24H21ClN4O
Article Open Access

The crystal structure of 1-((5-chloro-3-methyl-1-phenyl-1H-pyrazole-4-yl)methyl)-1,3-diphenylurea, C24H21ClN4O

  • Xing-Tao Zhang EMAIL logo , Hai-Chao Wang , Teng Wang and Chao Liu
Published/Copyright: July 23, 2018

Abstract

C24H21ClN4O, monoclinic, P21/n (no. 14), a = 10.2630(11) Å, b = 17.8954(16) Å, c = 12.3517(14) Å, β = 102.510(11)°, V = 2214.7(4) Å3, Z = 4, Rgt(F) = 0.0569, wRref(F2) = 0.1617, T = 293(2) K.

CCDC no.: 1854761

The crystal structure is shown in the figure. Tables 1 and 2 contain details on crystal structure and measurement conditions and a list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal:Block, clear light colourless
Size:0.22 × 0.17 × 0.15 mm
Wavelength:Mo Kα radiation (0.71073 Å)
μ:0.2 mm−1
Diffractometer, scan mode:SuperNova, ω-scans
θmax, completeness:26°, >99%
N(hkl)measured, N(hkl)unique, Rint:11005, 4348, 0.050
Criterion for Iobs, N(hkl)gt:Iobs > 2 σ(Iobs), 2365
N(param)refined:272
Programs:CrysAlisPRO [1], SHELX [2]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

AtomxyzUiso*/Ueq
Cl10.05912(8)0.15927(4)0.02375(7)0.0717(3)
N10.2668(2)0.07542(12)0.1289(2)0.0515(6)
N30.1547(2)0.02605(13)−0.2413(2)0.0552(6)
C90.2845(3)−0.01265(15)0.0147(3)0.0570(8)
N20.3407(2)0.01360(13)0.1140(2)0.0588(7)
N40.1926(3)−0.02079(13)−0.4069(2)0.0687(8)
H40.2196420.023875−0.4153760.082*
C70.1668(3)0.08574(14)0.0372(2)0.0479(7)
C10.4306(3)0.12602(17)0.2826(3)0.0676(9)
H10.4979600.1114120.2474520.081*
O10.0973(2)−0.09276(11)−0.2941(2)0.0760(7)
C80.1740(3)0.03119(15)−0.0374(2)0.0502(7)
C120.2234(3)0.09440(14)−0.2521(2)0.0479(7)
C60.2987(3)0.11409(14)0.2327(2)0.0480(7)
C50.1990(3)0.13585(15)0.2842(3)0.0565(8)
H50.1101080.1273630.2504790.068*
C210.1654(3)−0.14665(16)−0.4905(3)0.0645(9)
H210.130661−0.165319−0.4323970.077*
C200.2019(3)−0.07217(15)−0.4922(3)0.0554(8)
C30.3618(4)0.18235(17)0.4375(3)0.0752(10)
H30.3831960.2053380.5066190.090*
C180.0838(3)0.02086(16)−0.1501(2)0.0590(8)
H18A0.041109−0.027656−0.1528340.071*
H18B0.0143880.058601−0.1605980.071*
C250.2504(4)−0.04602(18)−0.5795(3)0.0813(11)
H250.2750830.003906−0.5811570.098*
C40.2320(4)0.17067(16)0.3872(3)0.0677(9)
H4A0.1646410.1860540.4219140.081*
C130.3599(3)0.09576(17)−0.2343(3)0.0691(9)
H130.4088140.051934−0.2174420.083*
C190.1460(3)−0.03329(17)−0.3131(3)0.0553(8)
C150.3548(5)0.2271(2)−0.2636(3)0.0851(12)
H150.3992260.271868−0.2681000.102*
C100.3367(4)−0.08157(18)−0.0299(3)0.0853(11)
H10A0.394578−0.067639−0.0780940.128*
H10B0.263440−0.110380−0.0707390.128*
H10C0.385718−0.1108900.0304490.128*
C230.2293(4)−0.1668(2)−0.6632(3)0.0852(11)
H230.239081−0.198639−0.7204210.102*
C140.4243(4)0.1627(2)−0.2416(3)0.0886(12)
H140.5167480.163554−0.2311270.106*
C220.1813(3)−0.19270(19)−0.5763(3)0.0735(10)
H220.158446−0.242909−0.5745020.088*
C20.4618(4)0.16000(19)0.3857(3)0.0829(11)
H20.5506820.1678150.4202990.100*
C240.2633(4)−0.0928(2)−0.6654(3)0.0944(13)
H240.295076−0.074003−0.7249920.113*
C170.1540(4)0.15958(19)−0.2742(3)0.0844(12)
H170.0613670.159319−0.2859940.101*
C160.2208(5)0.2259(2)−0.2791(4)0.1045(15)
H160.1729510.270244−0.2931580.125*

Source of material

The synthesis pathway of the title compound begins with the reaction of the Vilsmeier-Haack reagent (DMF/POCl3) and 5-methyl-2-phenyl-2,4-dihydro-3H-pyrazole-3-one. The obtained 1H-pyrazole-4-carbaldehyde intermediate and aniline were reacted in ethanol at room temperature, to form the Schiff base derivative that was purified by recrystallization from ethanol. The corresponding secondary amine was obtained by the reduction of corresponding Schiff base using sodium borohydride. Lastly, the secondary amine was reacted with phenyl isocyanate in CHCl3 to afford the title compound. Single crystals were obtained by the slow evaporation of acetone/acetonitrile solutions.

Experimental details

All H atoms were positioned geometrically (C—H = 0.93 Å for the aromatic H atoms and C—H = 0.96 Å for the aliphatic H atoms) and were refined as riding, with Uiso(H) = 1.2Ueq(C) and Uiso(H) = 1.2Ueq(N).

Discussion

Many pyrazole derivatives have been reported to possess potent anticancer activities in vitro and in vivo, and much attention was paid to the discovery of Ser/Thr kinases inhibitors based on pyrazole core. In our previous research, [3], [4] we were able to demonstrate that a series of 5-phenyl-1H-pyrazole-3-amines and their urea derivatives displayed potent antiproliferative activities against human melanoma cells. In continuation of our earlier studies, and with a view to better understand the SAR around these pyrazole-based anti-melanoma agent, we report the synthesis and crystal structure of a 5-phenyl-1H-pyrazole-4-urea derivative.

In title compound, all bond lengths and angles within the N-phenylpyrazole core are comparable with those reported for the similar pyrazole derivatives [5], [6], [7] (cf. the figure). The C6—N1 bond [1.431(3) Å] allows a rotation of the phenyl relative to the pyrazole ring, thus the dihedral angle between the corresponding ring planes is 42.0(4)°.

Acknowledgements

This work was supported by the Key Project of Natural Science Research in the Colleges and Universities in Anhui Province (No. KJ2017ZD36).

References

Oxford Diffraction Ltd., CrysAlisPRO, Abingdon, Oxfordshire, England, (2006).Search in Google Scholar

Sheldrick, G. M.: SHELXT – integrated space-group and crystal-structure determination. Acta Crystallogr. A71 (2015) 3–8.10.1107/S2053273314026370Search in Google Scholar PubMed PubMed Central

Li, Q. S.; Lu, X. H.; Yang, Y.; Ruan, B. F.; Yao, R. S.; Liao, C. Z.: Discovery and pharmacophore studies of novel pyrazole-based anti-melanoma agents. Chem. Biodivers. 12 (2015) 116–132.10.1002/cbdv.201400143Search in Google Scholar PubMed

Dong, J. J.; Li, Q. S.; Wang, S. F.; Li, C. Y.; Zhao, X.; Qiu, H. Y.; Zhao, M. Y.; Zhu, H. L.: Synthesis, biological evaluation and molecular docking of novel 5-phenyl-1H-pyrazol derivatives as potential BRAF(V600E) inhibitors. Org. Biomol. Chem. 11 (2013) 6328–6337.10.1039/c3ob40776dSearch in Google Scholar PubMed

Buriol, L.; Frizzo, C. P.; Prola, L. D. T.; Moreira, D. N.; Marzari, M. R. B.; Scapin, E.; Zanatta, N.; Bonacorso, H. G.; Martins, M. A. P.: Regioselective reaction of mesoionic 4-trifluoroacetyl-1,3-oxazolium-5-olates and phenylhydrazine: synthesis of trifluoromethyl substituted pyrazole and 1,2,4-triazine derivatives. Catal. Lett. 141 (2011) 1130–1135.10.1007/s10562-011-0571-9Search in Google Scholar

Beck, J. R.; Wright, F. L.: Synthesis of 1-aryl-5-(trifluoromethyl) -1H-pyrazole-4-carboxylic acids and esters. J. Heterocycl. Chem. 24 (1987) 739–740.10.1002/jhet.5570240338Search in Google Scholar

Touzot, A.; Soufyane, M.; Berber, H.; Toupet, L.; Mirand, C.: Synthesis of trifluoromethylated pyrazoles from trifluoromethylenaminones and monosubstituted hydrazines. J. Fluorine Chem. 125 (2004) 1299–1304.10.1016/j.jfluchem.2004.03.007Search in Google Scholar

Received: 2018-04-23
Accepted: 2018-07-11
Published Online: 2018-07-23
Published in Print: 2018-08-28

©2018 Xing-Tao Zhang et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Articles in the same Issue

  1. Cover and Frontmatter
  2. Crystal structure of 2-amino-4-(2,4-dinitrophenyl)-3-cyano-7,7-dimethyl-5-oxo-4H-5,6,7,8-tetrahydrobenzo-pyran, C18H16N4O6
  3. Crystal structure of catena-poly[(μ3-5-carboxy-2-(pyridin-4-yl)benzoato-κ5O,O′:O′′,O′′′:O′′′)(1,10-phenanthroline-κ2N,N′)cadmium(II)], C100H60N12O16Cd4
  4. Crystal structure of 2-amino-4-(3,4,5-trimethoxy-phenyl)-7-methyl-5-oxo-4H,5H-pyrano[4,3-b]pyran-3-carbonitrile, C19H18N2O6
  5. Crystal structure of 1-{4-[(2-hydroxy-5-methyl benzylidene)amino]phenyl}ethanone O-ethyl-oxime, C18H20N2O2
  6. Crystal structure of bis{4-methyl-2-((E)-((4-((E)-1-(ethoxyimino)ethyl)phenyl)imino)methyl)phenolato-κ2N,O)}copper(II), C36H38CuN4O4
  7. Crystal structure of bis{5-methoxy-2-((E)-((4-((E)-1-(methoxyimino)ethyl)phenyl)imino)methyl)phenolato-κ2N,O}nickel(II), C34H34N4NiO6
  8. Crystal structure of poly[μ8-3-carboxyphthalat-κ8-O:O1,O1,O1:O2:O3,O3:O4)silver(I)], C9H4Ag2O6
  9. Crystal structure of 2-((E)-((4-((E)-1-(hydroxyimino)ethyl)phenyl)iminio)methyl)-5-methoxyphenolate, C16H16N2O3
  10. Crystal structure of (E)-1-(4-(((E)-2-hydroxy-3-methoxybenzylidene)amino)phenyl)ethan-1-one oxime, C16H16N2O3
  11. The crystal structure of 2-(tert-butyl)-4-chloro-6-phenyl-1,3,5-triazine, C13H14Cl1N3
  12. Crystal structure of (6,6′-(((((2-aminoethyl)azanediyl)bis(ethane-2,1-diyl))bis(azanylylidene))bis(methanylylidene))bis(2,4-dichlorophenolato)-κ6N,N′,N′′,N′′′,O,O′)cadmium(II) – ethanol – water (1/1/1), C22H28CdCl4N4O4
  13. Crystal structure of 6-chloro-N-methylpyrimidin-4-amine, C5H6ClN3
  14. Synthesis and crystal structure of bis{((E)-((4-((E)-1-(methoxyimino)ethyl)phenyl)imino)methyl)-2-naphtholato-κ2N,O}nickel(II), C40H34N4NiO4
  15. Crystal structure of (E)-2-(4-bromophenyl)ethenesulfonyl fluoride (C8H6BrFO2S)
  16. Synthesis and crystal structure of 2,2′-ethylenedioxybis(benzimide)-2,2′-bis[O-(1-propyloxyamide)]oxime-4,4′,6,6′-tetrachlorodiphenol, C36H34Cl4N4O8
  17. Crystal structure of bis(N-(1-(pyrazin-2-yl)ethylidene)nicotinohydrazonato-κ3N,N′,O)cadmium(II) – methanol (1/1), C26H28N10O4Zn
  18. Crystal structure of diaqua-(N-(1-(pyrazin-2-yl)ethylidene)nicotinohydrazonato-κ3N,N′,O)-bis(nitrato-κ2O,O′)samarium(III), C12H14N7O9Sm
  19. Crystal structure of hexaaqua-{(E)-N′-(1-(pyrazin-2-yl)ethylidene)isonicotinohydrazide-κ3N,N′,O}praseodym(III) trichloride monohydrate, C12H25Cl3N5O8Pr
  20. Crystal structure of methyl 4-(3-cyanophenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydro-quinoline-3-carboxylate, C21H22N2O3
  21. Crystal structure of ethyl 2-amino-4-(2-methoxyphenyl)-5-oxo-4H,5H-pyrano[3,2-c]chromene-3-carboxylate, C22H19NO6
  22. Crystal structure of 2,12-dibromo-5,15-dihexyl-5,15-dihydrobenzo [1,2-b:5,6-c′]dicarbazole, C38H38Br2N2
  23. Crystal structure of ethyl 2-amino-4-(3-hydroxy-4-methoxyphenyl)-5-oxo-4H,5H-pyrano[3,2-c]chromene-3-carboxylate, C22H19NO7
  24. Crystal structure of ethyl 2-amino-4-(3,4-dimethylphenyl)-5-oxo-4H,5H-pyrano[3,2-c] chromene-3-carboxylate, C23H21NO5
  25. Crystal structure of 2-hydroxy-N′-(pyrimidin-2-yl)benzohydrazide, C11H10N4O2
  26. Crystal structure of 2-(3,4-dimethylphenyl)-1,8-naphthyridine, C16H14N2
  27. Crystal structure of ethyl 4-(3,4-dimethylphenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate, C23H29NO3
  28. Crystal structure of ethyl 4-(3-cyanophenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate, C22H24N2O3
  29. Crystal structure of 7β,9β-dihydroxy-15-oxo-ent-kauran-16-en-19,6β-olide, C20H26O5
  30. Crystal structure of Ent-7β,20-epoxy-kaur-16-en-1β,6α,7α,14α,15α-pentaol-20-one, C20H30O8
  31. Crystal structure of 1,4-bis(benzo[d][1,3]dioxol-5-ylmethyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-yl acetate, C22H20O8
  32. Crystal structure of methyl 2-((4-((2-nitrophenoxy)methyl)-1H-1,2,3-triazol-1-yl)methyl) benzoate, C18H16N4O5
  33. Crystal structure of diaqua-bis(5-carboxy-1-methyl-1H-imidazole-4-carboxylato-κ2N,O)zinc(II), C12H14N4O10Zn
  34. Hydrothemal synthesis and crystal structure of triaqua-bis(5-carboxy-1-methyl-1H-imidazole-4-carboxylato-κ2N,O1O)manganese(II), C12H16N4O11Mn
  35. Redetermination of methyl 4-(4-chlorophenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydro-quinoline-3-carboxylate, C20H22ClNO3
  36. Crystal structure of bis{1-[(benzotriazol-1-yl)methyl]-1-H-1,3-(2-methyl-imdazol)-κN}-dithiocyano-κN-zinc(II) C24H22N12S2Zn
  37. Crystal structure of (5-fluoro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl furan-2-carboxylate, C10H7FN2O5
  38. Crystal structure of bis(η6-cymene)-tri-μ2-chlorido-ruthenium(II) tetrafluoroborate, C20H28BCl3F4Ru2
  39. Crystal structure of 3,6-diphenyl-7H-[1,2,4]-triazolo[3,4-b][1,3,4]thiadiazine, C16H12N4S
  40. Synthesis and crystal structure of 1,3-bis[(3,4-dicyano)phenoxy]-4,6-dinitro-benzene, C22H8N6O6
  41. Crystal structure of ethyl 2-amino-4-(2,6-dichlorophenyl)-7-methyl-5-oxo-4H,5H-pyrano [4,3-b]pyran-3-carboxylate, C18H15Cl2NO5
  42. Crystal structure of poly[μ3-hydroxy-(μ5-(5-(2-carboxylatophenoxy)isophthalato-κ6O1:O2:O3:O4:O5,O6)-(μ2-1,4-di(1H-imidazol-1-yl)butane-κ2N:N′)dicobalt(II)] hemihydrate, C25H22Co2N4O8.5
  43. Crystal structure of methyl 4-(4-bromophenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate, C20H22BrNO3
  44. Crystal structure of 9,10-dimethoxy-5,6-dihydro-[1,3]dioxolo[4,5-g]isoquinolino[3,2-a]isoquinolin-7-ium 5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-7-olate trihydrate, C35H33NO12
  45. Crystal structure of 2,5-bis(4-(10H-phenothiazin-10-yl)phenyl)-1,3,4-oxadiazole, C38H24N4OS2
  46. The crystal structure of (E)-2-(4-hydroxyphenyl)-5-(prop-1-en-1-yl)benzofuran-3-carbaldehyde, C18H14O3
  47. Crystal structure of bis{5H-dibenzo[c,f][1,5]oxabismocin-12(7H)-yl} carbonate, C29H24O5Bi2
  48. Crystal structure of ethyl-5-formyl-3,4-dimethylpyrrole-2-carboxylate — N-(5-ethoxycarbonyl-3,4-dimethylpyrrole)-2-methylene-5-nitrobenzene-1,2-diamine (1:1), C26H31N5O7
  49. Crystal structure of (E)-2-(1-((2-aminophenyl)imino)ethyl)-6-bromo-4-chlorophenol, C14H12BrClN2O
  50. Crystal structure of (Z)-2-(4-chlorophenyl)-4-(furan-2-yl(phenylamino)methylene)-5-methyl-2,4-dihydro-3H-pyrazol-3-one, C21H16ClN3O2
  51. Crystal structure of N2,N4-dibutyl-6-chloro-N2,N4-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine, C31H58ClN7 – Important intermediate of Chimassorb 119 synthesis
  52. Crystal structure of 1-(5-bromo-2-(4-methoxyphenyl)-1H-indol-7-yl)ethanone oxime, C17H15BrN2O2
  53. Crystal structure of poly-{diaqua-bis[(μ2-3-nitrobenzenesulfonylglycine-κ3N:O:O′)(4,4′-bipyridine)manganese(II)]}-dimethylformamide (1/1), C39H35Mn2N9O15S2
  54. Crystal structure of 4-(dimethylamino)-1-(prop-2-yn-1-yl)pyridin-1-ium perchlorate, C10H13ClN2O4
  55. Crystal structure of 2-amino-5-oxo-4-(4-chloro-phenyl)-4,5,6,7-tetrahydro-cyclopenta[b]pyran-3-carbonitrile, C15H11ClN2O2
  56. Crystal structure of triaqua-(pyridine-2,6-dicarboxylato-κ3O,N,O′)cobalt(II) – 6-phenyl-1,3,5-triazine-2,4-diamine (1/1), C16H18CoN6O7
  57. Crystal structure of ethyl 2-amino-4-(3-cyanophenyl)-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carboxylate, C21H22N2O4
  58. Crystal structure of 2-(4-chloro-2,6-dinitrophenyl)-1-(4-chloro-3-nitrophenyl)diazene 1-oxide, C12H5Cl2N5O7
  59. Crystal structure of 3,4-dimethyl-2,6-dinitrophenol, C8H8N2O5
  60. Crystal structure of 1,2-dimethyl-3,5-dinitrobenzene, C8H8N2O4
  61. Crystal structure of ethyl 4-(3-chlorophenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate, C21H24ClNO3
  62. Crystal structure of N-(4-chlorophenyl)-2-(2,6-dichlorophenyl)acetamide, C14H10Cl3NO
  63. Crystal structure of 2-amino-4-(4-fluorophenyl)-3-cyano-5-oxo-4H,5H-pyrano[3,2c] chromene, C19H11FN2O3
  64. The crystal structure of (4-nitrophenyl) (5-ferrocenyl-3-(trifluoromethyl)-1H-pyrazol-1-yl) methanone, C21H12F3FeN3O3
  65. Crystal structure of 5,5′-((3-hydroxy-4-methoxyphenyl)methylene)bis(1,3-diethyl-6-hydroxy-2-thioxo-2,3-dihydropyrimidin-4(1H)-one), C24H30N4O6S2
  66. Crystal structure of (3aR,4R,5R,7R,8S,9R,9aS,12R)-7-ethyl-5-(1-hydroxy-2-((R)-3-hydroxypyrrolidin-1-yl)ethoxy)-4,7,9,12-tetramethyldecahydro-4,9a-propanocyclopenta[8]annulene-3,8-diol – a pleuromutilin derivative, C26H41NO5
  67. Crystal structure of bis(μ2-3-formyl-5-methoxy-2-oxidobenzoato-κ3O,O′:O′)-hexapyridine-dicadmium(II) – pyridine (1/1), C53H47Cd2N7O10
  68. Crystal structure of ethyl 2-amino-4-(3-methoxyphenyl)-5-oxo-4H,5H-pyrano[3,2-c]chromene-3-carboxylate, C22H19NO6
  69. Crystal structure of methyl 4-(3,5-ditrifluoromethylphenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate — water (2/1), C22H21F6NO3
  70. Crystal structure of 2-(4-bromophenyl)-2,3-dihydro-1H-perimidine, C17H13BrN2
  71. Crystal structure of (5-ethyl-2-(4-methoxyphenyl)-1,3-dioxan-5-yl)methanol, C14H20O4
  72. Crystal structure of (E)-N-(4-bromo-2-(1-(hydroxyimino)ethyl)phenyl)benzamide, C15H13BrN2O2
  73. Crystal structure of caffeinium triiodide – caffeine (1/1), C16H21I3N8O4
  74. Crystal structure of methyl 2-methyl-4-(3-methoxyphenyl)-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate, C19H21NO4
  75. Crystal structure of (E)-3-(3,5-di-tert-butyl-4-hydroxyphenyl)-1-phenylprop-2-en-1-one, C23H28O2
  76. Crystal structure of 1,4-bis(2-azidoethyl)piperazine-1,4-diium dichloride, C8H18N8Cl2
  77. The crystal structure of dichlorido-(1,3-bis(2,6-dimethylphenyl)-1H-imidazol-2(3H)-ylidene)-(morpholine-κ1N)palladium(II), C23H29Cl2N3OPd(II)
  78. The crystal structure of 1-((5-chloro-3-methyl-1-phenyl-1H-pyrazole-4-yl)methyl)-1,3-diphenylurea, C24H21ClN4O
  79. Crystal structure of 6-(2-bromoacetamido)tetrahydro-2H-pyran-2,3,4,5-Tetrayl tetraacetate, C16H22BrNO10
  80. Crystal structure of 5-methylpyrazine-2-carbohydrazide, C6H8N4O
  81. Crystal structure of catena-poly[(μ2-5-(tert-butyl)isophthalato-κ4O,O′:O′′,O′′′)(-4′-(pyridin-4-yl)-2,2′:6′,2′′-terpyridine-κ3N,N′,N′′)manganese(II)], C32H28N4O5Mn
Downloaded on 11.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2018-0154/html?lang=en
Scroll to top button